Dealogic and Perrigo

Perrigo: Last week saw generic-drug makers in the spotlight. Mylan offered to pay a 24% premium for rival Perrigo, valuing it at $28.9 billion. Counting this offer, total mergers-and-acquisitions volume has exceeded $1 trillion so far this year, according to Dealogic. Health care is.., according to Wall Street Journal and Mergers across the health-care sector show no signs of slowing. Investors are reveling in the frenzy, but the risk of acquirers overpaying has rarely been higher. (news.financializer.com). As reported in the news.